Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Immunogen begins mid-stage testing of experimental cancer compound, triggers $3M payment
Immunogen begins mid-stage testing of experimental cancer compound, triggers $3M payment
Immunogen begins mid-stage testing of experimental cancer compound, triggers $3M payment
Submitted by
admin
on October 20, 2011 - 12:45pm
Source:
Yahoo/AP
News Tags:
Immunogen
Sanofi
SAR3419
non-Hodgkin's lymphoma
Headline:
Immunogen begins mid-stage testing of experimental cancer compound, triggers $3M payment
Do Not Allow Advertisers to Use My Personal information
